# LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
> **NDA202157** · New Drug Application · Sponsor: HETERO LABS UNIT III · Approved 2011-11-18
## Drug
- **FDA Application Number:** NDA202157
- **Application type:** New Drug Application
- **Brand name:** LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- **Generic name:** Lamivudine
- **Active ingredients:** LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** HETERO LABS UNIT III
- **First approval:** 2011-11-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202157)
---
*AI Analytics · CC0 1.0*